DDReg Pharma Pvt Ltd

Home
India
Gurugram
DDReg Pharma Pvt Ltd

Call Directions Website Contact the practice

Incepted in the year 2009, the company is involved in a wide variety of regulatory & drug safety assignments which span across global markets.

DDReg is a global life sciences consulting firm specializing in regulatory affairs, pharmacovigilance, and quality services, accelerating product registrations and ensuring compliance through smart RegTech and deep industry expertise. Rich subject matter expertise gets combined with cutting edge technology solutions providing end to end support across pharma value chain. The company supports global pharmaceutical organizations for their needs to address regulatory challenges pertaining to Biologicals, Complex formulations, INDs, NDAs and Generics, Consumer Healthcare products and Medical Devices, in highly regulated markets as well as in complex emerging markets. The services portfolio includes Document management, Dossier support, pre-Approval and Post MA regulatory support, Submission management, Regulatory Intelligence, Regulatory Strategies, Feasibility Studies, Dossier compilation, submissions, Agency follow ups and approvals. The Drug Safety Vertical supports global organizations to manage their worldwide Safety Obligations by way of Case Management, Aggregate Reporting, Safety Compliances, Signal Detection and Risk Management. Functional and Operational Excellence are manifested through Strong Quality Management System, and Efficient Project Management.

14/10/2026

ONE APPROVAL. MULTIPLE STRATEGIC QUESTIONS.
Getting a product registered in Kenya is a major milestone, but the next challenge begins after approval.

Companies need to evaluate:

Which markets align with their growth goals?
How can regulatory efforts be optimized?
What should the next submission strategy look like?

A successful regional expansion is built by making the right decisions before entering the next market.
Your first approval is not the destination. It is the foundation for what comes next.

For more: https://tinyurl.com/3axjzap9

13/10/2026

KENYA: A MARKET ENTRY OR A REGIONAL STRATEGY?

For pharmaceutical companies, entering Kenya is not only about securing one approval. It can be an opportunity to build a stronger foundation for expansion across East Africa.

A successful regional strategy starts with understanding:

✓ Regulatory pathways
✓ Market priorities
✓ Registration requirements
✓ Future expansion goals

Choosing the right entry market can influence the success of your broader regional plans.

The right strategy turns a local launch into a regional opportunity.

Read More: https://tinyurl.com/3htkw55d

12/10/2026

Small Movements, Big Impact
From taking a morning walk to typing a message, our joints are the unsung heroes of our everyday lives. But for millions of people worldwide living with arthritis, these simple tasks can become major hurdles.

This World Arthritis Day (October 12), let’s shift the focus toward better mobility, timely care, and an improved quality of life. Joint pain shouldn’t keep anyone from chasing their goals—this year's global theme reminds us to help everyone Achieve Their Dreams by moving freely and living fully!

Take a step toward joint health today:

1. Listen to your body and don't ignore persistent stiffness.
2. Stay active with low-impact exercises like yoga or walking.
3. Prioritise early diagnosis to protect your future mobility.

Let’s spread awareness and build a pain-free tomorrow!

Learn More: https://www.ddregpharma.com/

11/10/2026

In Mexico, COFEPRIS does not grant sanitary registrations for dietary supplements. But that does not mean supplements can enter the market without regulatory compliance.

Companies still need to consider:

PRODUCT CLASSIFICATION → INGREDIENTS → LABELING → ADVERTISING → MARKET COMPLIANCE

The key takeaway:

No sanitary registration ≠ no regulatory requirements.

Navigating these requirements early can help support a compliant and well-planned market entry in Mexico.

Need support with Mexico regulatory strategy?
Talk to DDReg about your global market-entry and regulatory requirements.

For more: https://tinyurl.com/y4rn4uu6

10/10/2026

Some of the most meaningful support begins with a simple question: “How are you doing?”

This World Mental Health Day, take a moment to check in with yourself and the people around you. Reach out, listen without judgment, and remind someone that they matter.

Every conversation matters. Every person matters.

Reach out to us: https://www.ddregpharma.com/

09/10/2026

A Q4 regulatory filing can be delayed long before submission day.

When multiple markets are involved, dossier readiness is only one part of the submission strategy. Differences in local documentation, Module 1 requirements, eCTD validation and country-specific product information can create avoidable delays if they are addressed too late.
A more structured approach starts with five priorities:
🔹 Market prioritization: Align filing sequence with business objectives, regulatory timelines and local requirements.
🔹 Dossier readiness: Prepare region-specific administrative documents, translations and product information alongside the core dossier.
🔹 Technical validation: Identify eCTD errors, metadata issues, broken hyperlinks and file-naming inconsistencies before submission.
🔹 Change alignment: Assess how changes to reference product information or dossier content affect each target market.
🔹 Submission planning: Coordinate dependencies, responsibilities and filing milestones through one integrated roadmap.

For organisations preparing multiple regulatory filings in Q4, early coordination can make the difference between a planned submission and a last-minute scramble.

Planning a multi-market filing? Plan with DDReg Pharma.

Learn More: https://tinyurl.com/bdffku9x

08/10/2026

WORLD SIGHT DAY 2026

Healthy vision is more than seeing clearly. It supports learning, independence, productivity and quality of life.

On World Sight Day, we join the global eye health community in raising awareness of the importance of accessible, quality eye care for everyone.
From prevention and early detection to innovative treatments and better access, every step toward stronger eye health can make a meaningful difference.
Let’s continue to support a future where avoidable sight loss is addressed and everyone has the opportunity to see their best.

DDReg Pharma: https://www.ddregpharma.com/

07/10/2026

That small gap between global detection and local action can create a much bigger pharmacovigilance challenge.

Different teams.
Different responsibilities.
Different reporting pathways.
But only one safety system.

When the handoff isn’t clear, accountability can get tangled too.

Global → Regional → Local → Regulatory

Are all the connections in your PV governance actually working?
DDReg | Connecting the dots in pharmacovigilance.

Learn More about: https://tinyurl.com/278hardc

06/10/2026

One EU approval could be the starting point for your next market — if you know how to leverage it.

An existing EU approval can provide valuable data, documentation and regulatory insights for a subsequent filing, but the next step depends on what can be reused, what must be adapted, and which local regulatory pathway applies.

Assessing your existing dossier against country- specific requirements early can help identify gaps, minimise unnecessary duplication and build a more efficient market-entry strategy.

DDReg helps pharmaceutical companies evaluate existing dossiers and navigate regulatory pathways for expansion into new markets.

Learn More: https://tinyurl.com/ynk7489b

05/10/2026

Choosing the right trial countries can influence more than recruitment and operational feasibility — regulatory timelines can shape how quickly your development programme gets underway. Evaluating these factors early can help sponsors build a more informed and coordinated global development strategy.

Before selecting a country, consider:

• Regulatory timelines — How long could approvals take?
• Submission requirements — What country-specific requirements apply?
• Start-up feasibility — How quickly can the trial move toward initiation?
• Development strategy — Does the country fit your broader global plan?

SELECT THE RIGHT COUNTRY. SET THE RIGHT PACE.

DDReg supports sponsors with regulatory strategy and clinical development planning across global markets.

Read More: https://tinyurl.com/prcx3e9y

Address

Units 444-451, Tower B2, 4-floor Spaze-I-Tech Park, Sector 49, Sohna Road
Gurugram
122018

Telephone

+911244361505-06

Website

https://www.ddregpharma.com/, https://resource.ddregpharma.com/, https://x.com/DDRegPharma, https://www.linkedin.com/com

Alerts

Be the first to know and let us send you an email when DDReg Pharma Pvt Ltd posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to DDReg Pharma Pvt Ltd: